Christopher E. Kevane

CIK 1486632 · EVP and Chief Legal Officer · last filed 2025-12-19

Christopher E. Kevane is an EVP and Chief Legal Officer who has filed 27 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for UTI, was dated Mar 27, 2026. Across all open-market trades the lifetime net is −$945.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.60M

Companies

2

Total Filings

27

Lifetime Open-Market Net

-$945.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UTI EVP and Chief Legal Officer 107,175 $24.30 $2.60M -$1.00M 21 2025-12-19
Nuverra Environmental Solutions, Inc. (NES) Delisted EVP & Chief Legal Officer 4,000 $2.15 $8.6K $58.0K 1 2013-12-12

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-27 UTI Notice (144) −23,654 -$888.1K EDGAR
2025-12-19 UTI Tax (F) −1,670 -$43.5K EDGAR
2025-12-12 UTI Mixed −3,710 -$410.5K EDGAR
2025-12-10 UTI Grant (A) +38,878 $0 EDGAR
2025-05-14 UTI Sell (S) −29,400 -$1.00M EDGAR
2025-05-12 UTI Notice (144) −29,400 -$1.00M EDGAR
2024-12-17 UTI Mixed +8,613 -$122.6K EDGAR
2024-12-10 UTI Mixed +5,884 -$148.8K EDGAR
2023-12-18 UTI Mixed +9,490 -$40.1K EDGAR
2023-12-13 UTI Mixed +16,001 -$73.4K EDGAR
Showing 110 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.